Sell Your Psychiatry Practice
Specialist M&A advisory for psychiatry practice owners — telepsychiatry, prescriber retention, and PC/MSO expertise.
The Market for Selling a Psychiatry Practice
Psychiatry is one of the most actively pursued specialties in healthcare M&A today. The national shortage of psychiatrists — with demand projected to exceed supply by 14,000–31,000 physicians by 2030 — makes every productive prescriber strategically valuable. PE platforms building behavioral health networks are paying premium multiples to acquire psychiatric capacity in markets where organic growth is not an option.
Telepsychiatry has reshaped the market. Since 2020, hybrid and fully remote psychiatry practices have expanded their addressable patient population beyond geographic limits. Multi-state licensed practices command meaningful premiums because they can scale without the capital and regulatory complexity of physical expansion. In-person-only practices are still attractive, but face a discount relative to telepsych-enabled peers.
Buyers are disciplined. Diligence focuses on physician retention commitments, controlled-substance compliance, non-owner prescriber capacity, payer mix, and PC/MSO structure. Practices with clean DEA records, strong non-owner prescriber rosters, and distributed patient panels command the top of the range. Practices where a single physician holds all of the clinical and referral relationships face meaningful multiple compression.
How Much Is My Psychiatry Practice Worth?
Psychiatry practices sell for 0.5x to 10.0x adjusted EBITDA. The single biggest variable is owner-physician compensation normalization — an adjustment that can shift EBITDA by $200K to $800K in a mid-size group before a multiple is ever applied.
Generalist advisors consistently misprice psychiatry practices. PC/MSO structure, DEA registration mechanics, telepsychiatry infrastructure, and multi-state licensure value all require sub-vertical fluency that most brokers don’t have. A practice that should trade at 7x gets quoted at 4x — and the owner never knows the difference.
Behavioral Health Business Broker’s psychiatry valuations are built on what buyers in this specific market are actually paying today — accounting for prescriber composition, payer mix, telepsych infrastructure, and clinical autonomy structure. You get a number that holds up through diligence, not one designed to secure your engagement.
| Practice Profile | Revenue Range | EBITDA Multiple | Primary Buyer |
|---|---|---|---|
| Solo psychiatrist, owner-dependent | $400K – $1.5M | 0.5x – 2.0x | Transition-focused buyers, small platforms |
| Small group, 2–5 prescribers, in-person or hybrid | $1.5M – $5M | 2.5x – 5.0x | PE-backed platforms, regional strategics |
| Mid-size, 5–15 prescribers, hybrid/telepsych | $4M – $12M | 5.0x – 7.5x | PE platforms, national strategic buyers |
| Multi-location / telepsych-led, multi-state licensed | $8M – $20M | 6.5x – 9.0x | Large PE sponsors, national platforms |
| Regional psychiatry platform, 15+ prescribers | $20M+ | 8.0x – 10.0x | Large PE sponsors, national strategic |
Psychiatry multiples are applied to adjusted EBITDA. Owner-physician compensation must be normalized to market rates for the physician role — not ownership distributions. This adjustment alone can change EBITDA by $200K–$800K in a typical mid-size group.
What Drives the Value of a Psychiatry Practice
Buyers don’t just buy EBITDA — they buy prescriber capacity they believe will still be there after you leave.
Physician Retention Premium
An owner-psychiatrist who commits to 12–24 months post-close signals continuity buyers pay for directly. A well-structured physician employment agreement can add 0.5–1.0x to the effective EBITDA multiple.
Non-Owner Prescriber Capacity
Every psychiatrist and PMHNP on your team beyond you is a multiple driver. Non-owner prescribers reduce key-person risk and make your practice a platform target instead of a transition transaction.
W-2 vs 1099 Classification
W-2 employed psychiatrists signal control, compliance, and predictable revenue. 1099 arrangements create misclassification risk that buyers price in — or walk away from.
Telepsychiatry Infrastructure
Multi-state licensure combined with a HIPAA-compliant telehealth platform is a standalone asset. Buyers building national platforms pay more for practices that don’t need infrastructure investment post-close.
Commercial Payer Concentration
Practices above 70% commercial payer mix command a meaningful premium over Medicaid-heavy peers at the same EBITDA — and attract a broader, better-capitalized buyer universe.
PC/MSO Structure Readiness
Buyer-ready PC/MSO structure reduces regulatory friction and accelerates diligence. Practices that require retrofitting during the transaction face timeline delays and price pressure.
Telepsychiatry and Practice Value
Since 2020, telepsychiatry has fundamentally reshaped what a psychiatry practice is worth. A psychiatrist licensed in multiple states seeing patients remotely is a categorically different asset from one practicing in a single in-person office — and buyers price that difference explicitly. Behavioral Health Business Broker positions telepsych-enabled practices with buyers who understand the infrastructure value, not just the current revenue.
Share of revenue from telehealth in hybrid psychiatry practices today. Buyers model telehealth revenue durability separately from in-person revenue — platforms matter.
Multi-state licensed practices attract a materially larger buyer pool. Each additional state license expands addressable patient population and platform value without proportional cost.
EBITDA multiple premium for dedicated telehealth infrastructure vs. ad-hoc video visits — HIPAA-compliant platform, established workflows, documented patient acquisition.
Prescriber capacity is what buyers are competing for — and the structure you negotiate determines what you keep, what you give up, and what your earn-out looks like. PC/MSO terms, DEA continuity, clinical autonomy protections, and employment agreements are all set in the first thirty days. Know what your practice is worth before you take the first call.
Clinical Autonomy & PC/MSO Structure After the Sale
What clinical autonomy looks like in a well-structured psychiatry transaction:
- Clinical decision-making authority stays with the physician
- Treatment protocols remain under your direction
- Referral relationships remain yours
- Staffing and hiring input preserved in employment agreement
- EHR transition timeline negotiated, not imposed
In most transactions, yes — with defined clinical authority written into the purchase agreement and employment contract. Behavioral Health Business Broker negotiates this explicitly, not as an afterthought.
Billing, HR, real estate, and compliance shift to the buyer’s management company. Clinical operations — treatment decisions, prescribing, patient relationships — remain with you under the PC/MSO structure.
Most transactions include a 12–24 month physician employment commitment. The structure of your exit after that period — continued part-time role, full departure, consulting — is negotiable and should be addressed in the LOI.
Who Buys Psychiatry Practices
The psychiatry buyer universe is active and well-capitalized. Matching your practice to the right buyer — not just the one that reaches out first — is one of the most important decisions in the process.
| Buyer Type | Typical Deal Size | What They Want | What They Pay For |
|---|---|---|---|
| Psychiatry-specific PE platforms | $3M – $20M revenue | Prescriber capacity, geographic expansion | Non-owner prescribers, telepsych, multi-state licensure |
| Broader behavioral health PE | $5M – $50M revenue | Integrated BH capacity, prescriber access | Prescriber retention, payer mix, clinical leadership |
| National strategic acquirers | $8M – $100M+ revenue | Market expansion, telehealth scale | Multi-state licensure, telepsych infrastructure, brand |
| Independent sponsors / healthcare PE | $10M+ revenue | Platform investment, prescriber roll-up | Management depth, margins, physician retention history |
How the Psychiatry Practice Sale Process Works
A psychiatry practice sale is a six-to-nine-month process that requires specialized attention to physician employment structures, DEA mechanics, and clinical autonomy protections. Behavioral Health Business Broker manages every step.
1. Confidential Valuation & Readiness Review
We build a detailed valuation normalizing owner-physician compensation, analyzing non-owner prescriber capacity, payer mix, and telepsych infrastructure. You get an honest range before making any decisions.
2. Financial Preparation & Normalization
Owner-physician comp normalization is the most consequential financial step in psychiatry M&A. We get this right — including splitting owner comp into fair physician salary vs. ownership distributions — before any buyer sees a number.
3. CIM & PC/MSO Structure Planning
We build a buyer-grade CIM and advise on PC/MSO structure, including how to present the professional corporation arrangement so buyers understand the clinical autonomy framework from the start.
4. Targeted Buyer Outreach
We approach psychiatry-specific buyers with active mandates — platforms that have proven track records with physician retention, that understand PC/MSO structure, and whose clinical autonomy commitments we can verify.
5. IOI, Management Meetings & LOI
We run competitive tension to improve price, earn-out structure, physician employment terms, and clinical autonomy protections. DEA transfer and PC/MSO structuring are negotiated in the LOI — not discovered in diligence.
6. Diligence, DEA Transfer & Close
We quarterback clinical, financial, legal, and payer-contract diligence. DEA registration transfer, controlled substance protocol documentation, and payer credentialing continuity are managed proactively — not reactively.
Why Psychiatry Practice Owners Choose BHBB
DEA Transfer Expertise
DEA registration continuity varies by transaction structure and controlled substance involvement. We manage this proactively so it doesn’t surface as a closing obstacle.
Telepsychiatry Economics
We model telehealth revenue durability, multi-state licensure value, and platform integration premiums. We don’t let buyers discount your infrastructure because they don’t understand what it cost to build.
PC/MSO Structuring
We ensure your Professional Corporation/Management Services Organization structure is buyer-ready before going to market — and advise on how to optimize it for your specific transaction.
Clinical Autonomy Protections
We negotiate clinical decision-making safeguards into transaction documents as enforceable commitments — tied to the specific buyers we advance, not boilerplate language.
Physician-Led Transaction Experience
We have closed psychiatry-practice transactions. We understand the concerns specific to physician sellers and structure processes that address them.
Frequently Asked Questions
Ready to Know What Your Practice Is Worth?
Psychiatry practices are among the most actively acquired assets in behavioral health M&A right now. Start with a confidential, no-obligation valuation built on your actual prescriber composition, payer mix, and telehealth infrastructure.